Trevi Therapeutics (TRVI)
Developing oral nalbuphine ER across three chronic-cough indications.
$15.19
vs last close+0.30 (+2.01%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 104.89% | 149.45M shares | |
|---|---|---|---|
| 226 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 4.44% | 6.32M shares | |
| 12 holders · as of Sep 17, 2026 | |||
| Adds to | 109.33% | ||
142.48M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 109.33%; nothing is left for Other.
13F, as of Jun 30, 2026
226 holders · 149.45M shares · 45 new positions · 135 increased · 60 reduced · 21 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Nea Management Company, LLC | 13.22M | 9.28% | 0 | Aug 14, 2026 |
| FMR LLC | 12.56M | 8.82% | +4.52M | Aug 13, 2026 |
| BlackRock, Inc. | 11.16M | 7.83% | +914.8K | Aug 7, 2026 |
| Frazier Life Sciences Management, L.P. | 9.94M | 6.98% | −100 | Aug 14, 2026 |
| Wellington Management Group LLP | 5.68M | 3.99% | +495.5K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 5.53M | 3.88% | +552.1K | Aug 13, 2026 |
| Vivo Capital, LLC | 5.09M | 3.58% | 0 | Aug 14, 2026 |
| Woodline Partners LP | 4.08M | 2.86% | +3.08M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Nea 18 Vge GP, LLCincl. Ali Behbahani, Carmen Chang +10 more | 10.50% | 15.07M | 13D | May 7, 2026 |
| Frazier Life Sciences Public Fund, L.P. | 7.00% | 8.51M | 13G | Nov 14, 2025 |
| FMR LLC | 6.30% | 8.04M | 13G | May 6, 2026 |
| BlackRock, Inc. | 5.60% | 6.80M | 13G | Oct 17, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 15, 2026 | Michael Thomas Heffernandirector | Sale · 2 lots | 21,052 | $15.09 | 6,351 |
House and Senate disclosures
Not reported.